Overview

Zaleplon 10mg Capsules Under Fasting Conditions

Status:
Completed

Trial end date:
2004-02-01

Target enrollment:

Participant gender:

Summary

The objective of this study was to compare the relative bioavailability of Zaleplon 10 mg Capsules manufactured by TEVA Pharmaceuticals USA and Sonata® 10 mg Capsules manufactured by Wyeth Laboratories in healthy, non-smoking adults under fasting conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Teva Pharmaceuticals USA

Treatments:

Zaleplon